| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.44T | 2.43T | 1.83T | 2.21T | 2.00T |
| Gross Profit | 1.11T | 1.15T | 830.27B | 984.41B | 911.82B |
| EBITDA | 706.28B | 768.38B | 508.68B | 660.82B | 636.20B |
| Net Income | 574.45B | 544.13B | 363.96B | 471.58B | 437.08B |
Balance Sheet | |||||
| Total Assets | 2.86T | 2.63T | 2.46T | 2.31T | 1.89T |
| Cash, Cash Equivalents and Short-Term Investments | 506.25B | 496.24B | 472.55B | 473.10B | 371.27B |
| Total Debt | 0.00 | 21.40B | 13.32B | 13.22B | 4.36B |
| Total Liabilities | 791.00B | 770.77B | 696.28B | 712.07B | 547.41B |
| Stockholders Equity | 2.07T | 1.86T | 1.76T | 1.60T | 1.35T |
Cash Flow | |||||
| Free Cash Flow | 330.75B | 423.80B | 317.73B | 359.37B | 227.23B |
| Operating Cash Flow | 539.73B | 582.17B | 434.72B | 426.27B | 283.39B |
| Investing Cash Flow | -96.49B | -169.61B | -125.15B | -41.76B | -55.63B |
| Financing Cash Flow | -425.36B | -388.84B | -325.01B | -256.53B | -167.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥3.87T | 67.46 | 53.12% | 1.11% | 12.01% | 26.66% | |
80 Outperform | ¥7.84T | 38.72 | 25.78% | 0.79% | 11.08% | 9.32% | |
79 Outperform | ¥21.57T | 19.86 | 26.01% | 1.79% | 0.49% | 6.10% | |
78 Outperform | ¥19.40T | 29.12 | 47.37% | 0.25% | 44.75% | 135.64% | |
78 Outperform | ¥1.94T | 15.60 | 21.73% | 2.29% | -4.28% | -9.67% | |
77 Outperform | ¥712.60B | 24.84 | 12.66% | 2.28% | 7.69% | -19.63% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |